TY - JOUR
T1 - Ribes fasciculatum var. Chinense leaf extract alleviates muscle atrophy caused by chronic inflammatory conditions through suppressing polarization into M1 macrophages
AU - Seo, Yeonju
AU - Lee, Eunbi
AU - Nam, Ju Ock
N1 - Publisher Copyright:
© 2024
PY - 2024/8
Y1 - 2024/8
N2 - Scope: Ribes fasciculatum Siebold & Zucc. var. chinense Maxim. Leave extract (RFE) has been reported to be non-toxic and suitable for consumption as a food, with documented anti-allergic and anti-obesity effects. Skeletal muscle atrophy in various chronic inflammatory conditions has been a significant concern, yet the role of RFE in ameliorating muscle atrophy remains to be demonstrated. This study aims to investigate the regulation of muscle atrophy by RFE in chronic inflammatory conditions. Methods and results: C2C12 myoblasts were treated with conditioned medium from Raw264.7 macrophages induced with LPS to simulate an inflammatory condition, or with conditioned medium containing RFE. This study found that muscle atrophy is significantly exacerbated in the inflammatory conditions, while RFE markedly improves this condition. RFE was found to recover the diminished differentiation capacity of myoblasts that occurs in chronic inflammatory conditions. Importantly, RFE mediates inhibition of polarization into pro-inflammatory M1 macrophages in Raw264.7 cells. This indicates that afzelin, active compound of RFE, interferes with the binding of LPS to the TLR4/MD2 complex. Conclusion: These results suggest that RFE can improve muscle atrophy in chronic inflammatory states by disrupting the binding of LPS to the TLR4/MD2 complex and inhibiting the polarization of macrophages into M1 phenotype.
AB - Scope: Ribes fasciculatum Siebold & Zucc. var. chinense Maxim. Leave extract (RFE) has been reported to be non-toxic and suitable for consumption as a food, with documented anti-allergic and anti-obesity effects. Skeletal muscle atrophy in various chronic inflammatory conditions has been a significant concern, yet the role of RFE in ameliorating muscle atrophy remains to be demonstrated. This study aims to investigate the regulation of muscle atrophy by RFE in chronic inflammatory conditions. Methods and results: C2C12 myoblasts were treated with conditioned medium from Raw264.7 macrophages induced with LPS to simulate an inflammatory condition, or with conditioned medium containing RFE. This study found that muscle atrophy is significantly exacerbated in the inflammatory conditions, while RFE markedly improves this condition. RFE was found to recover the diminished differentiation capacity of myoblasts that occurs in chronic inflammatory conditions. Importantly, RFE mediates inhibition of polarization into pro-inflammatory M1 macrophages in Raw264.7 cells. This indicates that afzelin, active compound of RFE, interferes with the binding of LPS to the TLR4/MD2 complex. Conclusion: These results suggest that RFE can improve muscle atrophy in chronic inflammatory states by disrupting the binding of LPS to the TLR4/MD2 complex and inhibiting the polarization of macrophages into M1 phenotype.
KW - Chronic inflammation
KW - M1 macrophage
KW - Macrophage polarization
KW - Muscle atrophy
KW - Muscle differentiation
UR - http://www.scopus.com/inward/record.url?scp=85196725424&partnerID=8YFLogxK
U2 - 10.1016/j.jff.2024.106332
DO - 10.1016/j.jff.2024.106332
M3 - Article
AN - SCOPUS:85196725424
SN - 1756-4646
VL - 119
JO - Journal of Functional Foods
JF - Journal of Functional Foods
M1 - 106332
ER -